Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (61-70 of 536) with videos related to

Pageof 54
Sort By:
Leukemia Research|May 30, 2006
A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapseJoseph Moore, Karen Seiter, Jonathan Kolitz, et al.
Cancer Informatics|March 20, 2015
Identification of medium-sized copy number alterations in whole-genome sequencingHatice Gulcin Ozer, Aisulu Usubalieva, Adrienne Dorrance, et al.
Briefings in Bioinformatics|October 11, 2015
Statistical methods for detecting differentially methylated regions based on MethylCap-seq dataDeepak N Ayyala, David E Frankhouser, Javkhlan-Ochir Ganbat, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 26, 2008
Enzyme kinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductaseXiaohui Wei, Guowei Dai, Zhongfa Liu, et al.
Anticancer Research|February 13, 2010
Disulfide-linked liposomes: effective delivery vehicle for Bcl-2 antisense oligodeoxyribonucleotide G3139Wanlop Weecharangsan, Bo Yu, Shujun Liu, et al.
The AAPS Journal|December 31, 2010
Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cellsPing Chen, Josephine Aimiuwu, Zhiliang Xie, et al.
Proteomics. Clinical Applications|December 8, 2010
Simultaneous metabolic labeling of cells with multiple amino acids: Localization and dynamics of histone acetylation and methylationChen Ren, Shujun Liu, Kalpana Ghoshal, et al.
International Journal of Pharmaceutics|October 2, 2010
Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acidHong Li, Yanhui Lu, Longzhu Piao, et al.
Nature Communications|February 4, 2026
Human type-1 innate lymphoid cells control leukemia stem cell differentiation and limit acute myeloid leukemia developmentZhenlong Li, Rui Ma, Hejun Tang, et al.
Journal of Proteome Research|January 6, 2007
Histone H4 N-terminal acetylation in Kasumi-1 cells treated with depsipeptide determined by acetic acid-urea polyacrylamide gel electrophoresis, amino acid coded mass tagging, and mass spectrometryLiwen Zhang, Xiaodan Su, Shujun Liu, et al.
Pageof 54

Showing results (61-70 of 536) with videos related to

Sort By:
Pageof 54
Leukemia Research|May 30, 2006
A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapseJoseph Moore, Karen Seiter, Jonathan Kolitz, et al.
Cancer Informatics|March 20, 2015
Identification of medium-sized copy number alterations in whole-genome sequencingHatice Gulcin Ozer, Aisulu Usubalieva, Adrienne Dorrance, et al.
Briefings in Bioinformatics|October 11, 2015
Statistical methods for detecting differentially methylated regions based on MethylCap-seq dataDeepak N Ayyala, David E Frankhouser, Javkhlan-Ochir Ganbat, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 26, 2008
Enzyme kinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductaseXiaohui Wei, Guowei Dai, Zhongfa Liu, et al.
Anticancer Research|February 13, 2010
Disulfide-linked liposomes: effective delivery vehicle for Bcl-2 antisense oligodeoxyribonucleotide G3139Wanlop Weecharangsan, Bo Yu, Shujun Liu, et al.
The AAPS Journal|December 31, 2010
Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cellsPing Chen, Josephine Aimiuwu, Zhiliang Xie, et al.
Proteomics. Clinical Applications|December 8, 2010
Simultaneous metabolic labeling of cells with multiple amino acids: Localization and dynamics of histone acetylation and methylationChen Ren, Shujun Liu, Kalpana Ghoshal, et al.
International Journal of Pharmaceutics|October 2, 2010
Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acidHong Li, Yanhui Lu, Longzhu Piao, et al.
Nature Communications|February 4, 2026
Human type-1 innate lymphoid cells control leukemia stem cell differentiation and limit acute myeloid leukemia developmentZhenlong Li, Rui Ma, Hejun Tang, et al.
Journal of Proteome Research|January 6, 2007
Histone H4 N-terminal acetylation in Kasumi-1 cells treated with depsipeptide determined by acetic acid-urea polyacrylamide gel electrophoresis, amino acid coded mass tagging, and mass spectrometryLiwen Zhang, Xiaodan Su, Shujun Liu, et al.
Pageof 54